查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614050

药物输送市场：按给药途径、车辆、应用和最终用户划分 - 全球预测 2025-2030

Drug Delivery Devices Market by Route of Administration (Inhalation, Injectable, Nasal), Vehicles (Dendrimer, Hydrogel, Liposome), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年给药市值为2,274.4亿美元，预计2024年将达2,502.3亿美元，复合年增长率为10.93%，到2030年将达到4,703.8亿美元。

药物传输市场包括各种旨在向人体施用治疗药物的产品。这包括吸入器、注射器、经皮吸收贴片和帮浦等设备，这些设备对于确保精确和受控的药物传输至关重要。这些设备的需求源于需要连续、精确剂量的慢性疾病的流行，例如糖尿病和气喘。这些设备用于各种环境，包括医院、居家医疗和诊所，以治疗从肿瘤到呼吸系统疾病的各种疾病。在最终用途领域，我们看到以患者为中心的解决方案取得了进展，这些解决方案可以提高依从性和结果等。

主要市场统计
基准年[2023] 2274.4亿美元
预测年份 [2024] 2502.3亿美元
预测年份 [2030] 4703.8亿美元
复合年增长率（%） 10.93%

关键的成长要素包括技术进步，例如整合数位健康资料的智慧给药系统、人口老化需要更多医疗保健解决方案以及研发投资的增加。由于医疗保健基础设施的扩大和意识的提高，亚太地区的新兴市场拥有巨大的潜在机会。然而，市场面临严格的监管要求、高昂的开发成本以及对设备安全性和有效性的担忧等限制。还存在竞争性定价压力和影响旧技术的专利到期等挑战。

创新领域包括开发基于奈米技术的输送系统、个人化医疗解决方案以及生物分解性和环保设备。研究标靶递送机制以最大限度地减少副作用并提高治疗效率也很重要。市场相关人员应专注于合作研究和伙伴关係，以利用技术进步并有效应对监管环境。

虽然这个市场的特点是技术创新迅速，但它也受到严格监管，以消费者安全和功效为核心。那些能够足够敏捷地将产品开发与监管标准和患者需求结合起来，同时利用数位医疗和药物输送不断扩大的交叉点的公司将有望取得成功。

市场动态：揭示快速发展的药物传输市场的关键市场洞察

供需的动态交互作用正在改变药物输送市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球慢性病流行导致药物传输需求增加
    • 药品和治疗药物的消费量增加
  • 市场限制因素
    • 併发症数量不断增加，需要提供治疗和药物的专业知识
  • 市场机会
    • 药物传输技术的进步
    • 越来越多采用自行注射装置
  • 市场挑战
    • 高端产品成本增加

波特五力：驾驭给药市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物输送市场的外部影响

外部宏观环境因素在塑造给药市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解给药市场的竞争状况

对药物输送市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵给药市场供应商绩效评估

FPNV定位矩阵是评估药物传输市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了药物输送市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，药物输送市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于全球慢性病的增加，药物输送的需求增加
      • 药品和治疗药物的消费量增加
    • 抑制因素
      • 提供治疗和药物所需的复杂性和专业知识增加
    • 机会
      • 药物传输技术的进步
      • 越来越多采用自行注射装置
    • 任务
      • 奢侈品成本上涨
  • 市场区隔分析
    • 给药途径： 为方便起见，优选口服给药途径。
    • 最终用户：医院需要能够治疗所有年龄层的综合药物输送阵列
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药物输送市场：依给药途径分类

  • 吸入
  • 可注射的
  • 鼻腔
  • 眼科
  • 口服
  • 话题
  • 经皮的

第七章 车辆给药市场

  • 树状聚合物
  • 水凝胶
  • 脂质体
  • 介孔材料
  • 胶束
  • 奈米粒子
  • 氮氧化物酶体
  • 鹰架

第八章 药物传输市场：依应用分类

  • 自体免疫疾病
  • 心血管疾病
  • 中枢神经系统疾病
  • 糖尿病
  • 感染疾病
  • 肿瘤学
  • 呼吸系统疾病

第九章 药物输送市场：依最终使用者分类

  • 门诊手术中心/诊所
  • 诊断中心
  • 家庭护理设置
  • 医院

第十章美洲给药市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太给药市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的给药市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新分子装置的精度革命增强了标靶药物输送
    • 新型穿戴式给药装置在美国推出，可望提高病患舒适度和依从性
    • 推出 UltraSafe PLUS，一种新型预填充式注射器，可提高给药的安全性和精确度
  • 战略分析和建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • AdminMed nanoBioSciences LLC
  • AptarGroup, Inc.
  • ARx, LLC
  • Bayer AG
  • Becton, Dickinson and Company
  • BioSerenTach Inc.
  • CosMED Pharmaceutical Co., Ltd.
  • Credence MedSystems, Inc.
  • E3D Elcam Drug Delivery Devices by Elcam Medical
  • Enable Injections, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline PLC
  • Innoture Medical Technology Limited
  • Kindeva Drug Delivery LP
  • Luye Pharma Group
  • Medtronic, Inc.
  • Midas Pharma GmbH
  • NanoPass Technologies Ltd.
  • Nitto Denko Corporation
  • Novartis AG
  • OraSure Technologies, Inc.
  • Owen Mumford Limited
  • Recipharm AB
  • Sparsha Pharma International Pvt. Ltd.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-B812DD5799B4

The Drug Delivery Devices Market was valued at USD 227.44 billion in 2023, expected to reach USD 250.23 billion in 2024, and is projected to grow at a CAGR of 10.93%, to USD 470.38 billion by 2030.

The drug delivery devices market encompasses a wide range of products designed to administer therapeutic agents into the human body. This includes devices like inhalers, injectors, transdermal patches, and pumps, which are crucial in ensuring precise, controlled delivery of medications. The necessity for these devices stems from the growing prevalence of chronic diseases, such as diabetes and asthma, which require continual, precision-based dosing. They find applications across hospitals, home care, and clinics, used for conditions ranging from oncology to respiratory disorders. At the end-use scope, advancements are particularly geared towards patient-centric solutions that improve adherence and outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 227.44 billion
Estimated Year [2024] USD 250.23 billion
Forecast Year [2030] USD 470.38 billion
CAGR (%) 10.93%

Key growth influencers include technological advancements like smart drug delivery systems that integrate digital health data, an aging population demanding more healthcare solutions, and increased R&D investments. Emerging markets in Asia-Pacific present robust potential opportunities due to expanding healthcare infrastructure and rising awareness. However, the market faces limitations such as stringent regulatory requirements, high-development costs, and concerns regarding device safety and efficacy. Challenges also include competition-induced pricing pressures and patent expirations affecting older technologies.

Innovation areas ripe for exploration include nanotechnology-based delivery systems, personalized medicine solutions, and the development of biodegradable, environmentally friendly devices. Research into targeted delivery mechanisms that minimize side effects and enhance therapeutic efficiency is also crucial. Market players should focus on collaborations and partnerships to leverage technological advancements and navigate regulatory landscapes effectively.

Navigating this market requires understanding its dynamic nature; while it is characterized by rapid innovation, it is also heavily regulated, with consumer safety and efficacy at its core. Companies that can align product development with regulatory standards and patient needs, while also being agile enough to capitalize on the growing intersection of digital health and drug delivery, stand poised for success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Devices Market

The Drug Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Prevalence of Chronic Diseases Globally Resulting in Increased Demand for Drug Delivery Devices
    • Rise in the Consumption of Drugs and Therapeutic Pharmaceuticals
  • Market Restraints
    • Increase in Complications and Expertise Required in Delivering Therapeutics and Drugs
  • Market Opportunities
    • Technology Advances in Drug Delivery Devices
    • Rising Adoption of Self Injectable Devices
  • Market Challenges
    • Increasing Cost of High End Products

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Devices Market

A detailed market share analysis in the Drug Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Devices Market

A strategic analysis of the Drug Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AdminMed nanoBioSciences LLC, AptarGroup, Inc., ARx, LLC, Bayer AG, Becton, Dickinson and Company, BioSerenTach Inc., CosMED Pharmaceutical Co., Ltd., Credence MedSystems, Inc., E3D Elcam Drug Delivery Devices by Elcam Medical, Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline PLC, Innoture Medical Technology Limited, Kindeva Drug Delivery L.P., Luye Pharma Group, Medtronic, Inc., Midas Pharma GmbH, NanoPass Technologies Ltd., Nitto Denko Corporation, Novartis AG, OraSure Technologies, Inc., Owen Mumford Limited, Recipharm AB, Sparsha Pharma International Pvt. Ltd., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Inhalation, Injectable, Nasal, Ocular, Oral, Topical, and Transdermal.
  • Based on Vehicles, market is studied across Dendrimer, Hydrogel, Liposome, Mesoporous Material, Micelle, Nanoparticle, Niosomes, and Scaffold.
  • Based on Application, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Infectious Diseases, Oncology, and Respiratory Diseases.
  • Based on End-user, market is studied across Ambulatory Surgery Centers/Clinics, Diagnostic Centers, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Chronic Diseases Globally Resulting in Increased Demand for Drug Delivery Devices
      • 5.1.1.2. Rise in the Consumption of Drugs and Therapeutic Pharmaceuticals
    • 5.1.2. Restraints
      • 5.1.2.1. Increase in Complications and Expertise Required in Delivering Therapeutics and Drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technology Advances in Drug Delivery Devices
      • 5.1.3.2. Rising Adoption of Self Injectable Devices
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing Cost of High End Products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Route of Administration: Higher preferences of oral route of administration owing to its convenience
    • 5.2.2. End-user: Need for comprehensive array of drug delivery devices in hospitals that can cater to treatments across all age groups
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Devices Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Inhalation
  • 6.3. Injectable
  • 6.4. Nasal
  • 6.5. Ocular
  • 6.6. Oral
  • 6.7. Topical
  • 6.8. Transdermal

7. Drug Delivery Devices Market, by Vehicles

  • 7.1. Introduction
  • 7.2. Dendrimer
  • 7.3. Hydrogel
  • 7.4. Liposome
  • 7.5. Mesoporous Material
  • 7.6. Micelle
  • 7.7. Nanoparticle
  • 7.8. Niosomes
  • 7.9. Scaffold

8. Drug Delivery Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cardiovascular Diseases
  • 8.4. Central Nervous System Disorders
  • 8.5. Diabetes
  • 8.6. Infectious Diseases
  • 8.7. Oncology
  • 8.8. Respiratory Diseases

9. Drug Delivery Devices Market, by End-user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers/Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Home Care Settings
  • 9.5. Hospitals

10. Americas Drug Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Delivery Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Revolutionizing Precision with New Molecular Device Enhances Targeted Drug Delivery
    • 13.3.2. New Wearable Drug Delivery Device Launches in U.S., Promising Enhanced Patient Comfort and Compliance
    • 13.3.3. Introducing UltraSafe PLUS, A New Pre-Filled Syringe Enhancing Safety and Precision in Medication Delivery
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. AdminMed nanoBioSciences LLC
  • 4. AptarGroup, Inc.
  • 5. ARx, LLC
  • 6. Bayer AG
  • 7. Becton, Dickinson and Company
  • 8. BioSerenTach Inc.
  • 9. CosMED Pharmaceutical Co., Ltd.
  • 10. Credence MedSystems, Inc.
  • 11. E3D Elcam Drug Delivery Devices by Elcam Medical
  • 12. Enable Injections, Inc.
  • 13. Gerresheimer AG
  • 14. GlaxoSmithKline PLC
  • 15. Innoture Medical Technology Limited
  • 16. Kindeva Drug Delivery L.P.
  • 17. Luye Pharma Group
  • 18. Medtronic, Inc.
  • 19. Midas Pharma GmbH
  • 20. NanoPass Technologies Ltd.
  • 21. Nitto Denko Corporation
  • 22. Novartis AG
  • 23. OraSure Technologies, Inc.
  • 24. Owen Mumford Limited
  • 25. Recipharm AB
  • 26. Sparsha Pharma International Pvt. Ltd.
  • 27. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NASAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DENDRIMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HYDROGEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY LIPOSOME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MESOPOROUS MATERIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY MICELLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NANOPARTICLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY NIOSOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY SCAFFOLD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS/CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DRUG DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES DRUG DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 114. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 123. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. DENMARK DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 127. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EGYPT DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 131. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. FINLAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 135. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. FRANCE DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 139. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. GERMANY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 143. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. ISRAEL DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 147. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. ITALY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 151. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NETHERLANDS DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 155. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. NIGERIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 159. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. NORWAY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 163. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. POLAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 167. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. QATAR DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 171. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. RUSSIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 175. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SAUDI ARABIA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH AFRICA DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 183. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SPAIN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 187. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. SWEDEN DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 191. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. SWITZERLAND DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 195. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. TURKEY DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED ARAB EMIRATES DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY VEHICLES, 2018-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. UNITED KINGDOM DRUG DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. DRUG DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 206. DRUG DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023